A randomised controlled trial of artemether-lumefantrine versus artesunate for uncomplicated plasmodium falciparum treatment in pregnancy - Test2 - elhamkhani - TriplyDB

A randomised controlled trial of artemether-lumefantrine versus artesunate for uncomplicated plasmodium falciparum treatment in pregnancy

A randomised controlled trial of artemether-lumefantrine versus artesunate for uncomplicated plasmodium falciparum treatment in pregnancy

http://www.wikidata.org/entity/Q28474447

about

A systematic review of the safety and efficacy of artemether-lumefantrine against uncomplicated Plasmodium falciparum malaria during pregnancy Artemisinin-Based Combination Therapy Versus Quinine or Other Combinations for Treatment of Uncomplicated Plasmodium falciparum Malaria in the Second and Third Trimester of Pregnancy: A Systematic Review and Meta-Analysis Artemether-lumefantrine treatment of uncomplicated Plasmodium falciparum malaria: a systematic review and meta-analysis of day 7 lumefantrine concentrations and therapeutic response using individual patient data The influence of pregnancy on the pharmacokinetic properties of artemisinin combination therapy (ACT): a systematic review The use of artemether-lumefantrine for the treatment of uncomplicated Plasmodium vivax malaria Update on the efficacy, effectiveness and safety of artemether-lumefantrine combination therapy for treatment of uncomplicated malaria.Artemisinin-based combination therapy in pregnant women in Zambia: efficacy, safety and risk of recurrent malaria Arthropod borne disease: the leading cause of fever in pregnancy on the Thai-Burmese border.Effect of pharmacogenetics on plasma lumefantrine pharmacokinetics and malaria treatment outcome in pregnant women Population pharmacokinetics and clinical response for artemether-lumefantrine in pregnant and nonpregnant women with uncomplicated Plasmodium falciparum malaria in Tanzania.Safety of artemether-lumefantrine in pregnant women with malaria: results of a prospective cohort study in Zambia.Pharmacokinetics of artemether and dihydroartemisinin in healthy Pakistani male volunteers treated with artemether-lumefantrine Artemether-lumefantrine: an option for malaria.Diagnostic and treatment difficulties of pyelonephritis in pregnancy in resource-limited settings.A novel histological grading scheme for placental malaria applied in areas of high and low malaria transmission.Malaria: an update on current chemotherapy.Treating severe malaria in pregnancy: a review of the evidence Pregnancy outcome in relation to treatment of murine typhus and scrub typhus infection: a fever cohort and a case series analysis.Coverage and efficacy of intermittent preventive treatment with sulphadoxine pyrimethamine against malaria in pregnancy in Côte d'Ivoire five years after its implementation.Drug-Resistant Malaria: The Era of ACT.Time-to-infection by Plasmodium falciparum is largely determined by random factors.Pharmacokinetic and pharmacodynamic characteristics of a new pediatric formulation of artemether-lumefantrine in African children with uncomplicated Plasmodium falciparum malaria Pharmacokinetics of dihydroartemisinin and piperaquine in pregnant and nonpregnant women with uncomplicated falciparum malaria.Interaction between artemether-lumefantrine and nevirapine-based antiretroviral therapy in HIV-1-infected patients.Relatively low prevalence of peripheral and placental Plasmodium infection at delivery in bangui, central african republic Intervals to Plasmodium falciparum recurrence after anti-malarial treatment in pregnancy: a longitudinal prospective cohort The interaction between artemether-lumefantrine and lopinavir/ritonavir-based antiretroviral therapy in HIV-1 infected patients.Surveillance for the safety and effectiveness of artemether-lumefantrine in patients with uncomplicated Plasmodium falciparum malaria in the USA: a descriptive analysis Lumefantrine and Desbutyl-Lumefantrine Population Pharmacokinetic-Pharmacodynamic Relationships in Pregnant Women with Uncomplicated Plasmodium falciparum Malaria on the Thailand-Myanmar Border.Pharmacovigilance of artemether-lumefantrine in pregnant women followed until delivery in Rwanda.Opposite malaria and pregnancy effect on oral bioavailability of artesunate - a population pharmacokinetic evaluation.The Safety of Artemisinin Derivatives for the Treatment of Malaria in the 2nd or 3rd Trimester of Pregnancy: A Systematic Review and Meta-Analysis.No association of phenotypic ABO blood group and malaria during pregnancy.Assessment of the safety of antimalarial drug use during early pregnancy (ASAP): protocol for a multicenter prospective cohort study in Burkina Faso, Kenya and Mozambique.Artemether-lumefantrine to treat malaria in pregnancy is associated with reduced placental haemozoin deposition compared to quinine in a randomized controlled trial Population pharmacokinetics of Artemether and dihydroartemisinin in pregnant women with uncomplicated Plasmodium falciparum malaria in Uganda Concomitant efavirenz reduces pharmacokinetic exposure to the antimalarial drug artemether-lumefantrine in healthy volunteers.A population pharmacokinetic model of piperaquine in pregnant and non-pregnant women with uncomplicated Plasmodium falciparum malaria in Sudan.Malaria prevalence, severity and treatment outcome in relation to day 7 lumefantrine plasma concentration in pregnant women.Pharmacokinetic properties of artemether, dihydroartemisinin, lumefantrine, and quinine in pregnant women with uncomplicated plasmodium falciparum malaria in Uganda.

P2860

Q17485688-15AF3A81-9172-4937-ACDC-70874ECB0990 Q26770713-470CC2CE-4530-489A-AB29-CF6D770A4B52 Q26783646-1F28AD29-22F9-4F2F-B85E-ECA414CDB426 Q28079877-4660DA08-378D-4615-9BA9-FC882E8D5C56 Q28478579-938BFA33-B04F-4BDD-9044-B303DBFBB153 Q33635019-A685560F-FF24-47AE-B13B-F8E5D22A1F63 Q33696767-5030C761-37FC-4697-91E2-5918ED826AAF Q33754684-55BE85A6-D7DD-46EE-9997-7A99F90367CE Q33869119-BAFC8B03-5240-40BC-A37D-21307D9E7F5F Q34058351-AA10D56B-B061-4576-8160-F7F39F15A34A Q34149822-D8CEEBE4-AF3C-441A-BB98-C63F2B7EBFA1 Q34221884-DB9F1DFF-E7A6-49D3-9A83-6719A8DAAD44 Q34267667-767D6B25-25D4-4B42-BD36-7B521B990C8E Q34341884-9790FFAA-6D45-4F8D-B1D1-8727A60F1592 Q34425614-52A58CCB-00DD-4C7D-89D7-5BB77598064A Q34433106-4CB5780D-FC09-43D9-8B49-1C468AFCE1D3 Q34456393-D9C91669-326B-4326-87FA-F63C3B923EC4 Q34549655-FEE8CBF9-1398-44D0-85E3-1679B940662B Q34579161-3FC1642F-B2B0-4337-9134-80CCCA2F0E66 Q34681141-E8B4D715-9B67-4FF4-B060-80531B480376 Q35030175-3A889D98-330E-4563-B3F8-9A1F3E22858C Q35191375-B1033ED1-8BEA-4E0D-B86C-C398505FFF70 Q35598379-4AD9B704-5A2B-4581-868C-5A420961DE1E Q35598594-1E12CB57-E6EA-4528-96E3-EA98253C4B72 Q35660355-404F4353-AD0D-4A04-B882-89EB6D355984 Q35667005-C3AE9CFF-DFAD-4CA0-BA7A-252168B1C072 Q35906361-B9071BE4-4A30-413B-B187-2A07A1ADB360 Q36069930-54CA1634-71A8-4270-9E58-6AA08D5B1EC9 Q36075976-522F4F4B-E0CE-44A9-8AB4-67A64DD4D50A Q36125279-9FC5E343-DD47-4C61-93BA-B7B4C0B8C0AD Q36125445-C89BF4E8-4C88-4E3B-9FE9-91DDC3AAAB24 Q36185610-13F935F6-15F5-4AF7-AC83-E7BD15274C8B Q36213243-B0E66F16-4C10-4FE9-9A5A-7C55D0A42869 Q36348696-16B71C0F-9707-41AF-B51E-A1CB7B03593C Q36368036-B7BF4672-B772-4672-9319-FB654470BE1E Q36411652-D5CFD400-6FEA-4453-964A-E001A96710A3 Q36438820-D3D39E39-A98F-42EE-B7FF-063A421B6DEA Q36552289-A80860A0-A59E-4709-91BD-0CC656057373 Q36898678-400B4A2A-D027-4F09-9C2F-7402922DADCE Q37263818-E3A5A251-6588-4403-9AF7-C91E8F8DBBAC

P2860

A randomised controlled trial of artemether-lumefantrine versus artesunate for uncomplicated plasmodium falciparum treatment in pregnancy

http://www.wikidata.org/entity/Q28474447

description

2008 nî lūn-bûn

@nan

2008 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

A randomised controlled trial ...... ciparum treatment in pregnancy

@ast

A randomised controlled trial ...... ciparum treatment in pregnancy

@en

A randomised controlled trial ...... ciparum treatment in pregnancy

@nl

type

label

A randomised controlled trial ...... ciparum treatment in pregnancy

@ast

A randomised controlled trial ...... ciparum treatment in pregnancy

@en

A randomised controlled trial ...... ciparum treatment in pregnancy

@nl

prefLabel

A randomised controlled trial ...... ciparum treatment in pregnancy

@ast

A randomised controlled trial ...... ciparum treatment in pregnancy

@en

A randomised controlled trial ...... ciparum treatment in pregnancy

@nl

P1433

Q28474447-309CE23D-FB24-4B18-A7E2-4195E88D6ABB

P1476

Q28474447-5AF9E62C-A0F9-4782-A957-A3853EC2FA75

P2093

Q28474447-0EA53675-3012-4328-8D15-E710D0462EE9

Q28474447-1571B9A4-03E3-4E9E-9285-D59B00495D59

Q28474447-1FC586C2-2BBD-43ED-A513-2AB9A43E132B

Q28474447-3AB104C8-5DFE-4886-B1B1-667DC1A307D6

Q28474447-606F1D42-539B-45A3-A5D2-FA77A9D9855C

Q28474447-8A9827C3-C43B-46D7-BD5D-F4B94F19242B

Q28474447-8B70BEE7-8AE4-4C54-BA68-3A61620DC0D2

Q28474447-8B861948-8BD0-4EC4-A770-F86B4BAEE08D

Q28474447-990213E3-F5CF-4C74-AFB9-66DC475532BB

P2860

Q28474447-01EC4B21-CCA3-444D-A399-3C0FBFBD4211

Q28474447-0287E44F-2689-4A1A-8861-E09AF451B1AD

Q28474447-0A764973-7DF9-4999-8EDD-C9F09E1BDFCE

Q28474447-0CD5C948-53E8-4730-B23F-C57BB71E87E1

Q28474447-13DDB7C5-32C6-469F-B807-62578BFBFE4D

Q28474447-18B80884-4563-4EBD-A2A2-C6E346E3639A

Q28474447-1C845329-9F05-4D72-B95B-B44E39755BB4

Q28474447-1E7E8258-46EE-4220-8A75-1C09048317D7

Q28474447-1FA040AD-0C13-4327-8ACE-FF99A9DEFC13

Q28474447-27B8C392-38EE-4601-89C7-895750B55866

P304

Q28474447-8206FF69-0D7D-47E3-B1EE-BACB604F7251

P31

Q28474447-17476733-2747-4CE0-BCC3-516EF151FF18

P3181

Q28474447-91CEEA6D-0A2D-4C19-9F3A-015B6547296E

P356

Q28474447-58685CA4-7722-4546-9356-F5D865257F7D

P407

Q28474447-B223A272-16CB-46FB-B883-9FD6B5A9C194

P433

Q28474447-8DC07270-8DFE-458D-AFE0-9D80896823A4

P478

Q28474447-4E5536C3-31EC-4AB6-959B-6A77C5D8D490

P50

Q28474447-45FB44DF-5B31-4012-9E8E-1CD0461A2C49

Q28474447-53BD1DDE-2AB2-48FF-AA9D-469E0C4015D0

Q28474447-D693D882-8D57-40CD-9A75-DCFED60EA893

Q28474447-F75DE884-4A4D-4420-AD84-ED3F2E1E0ECE

Q28474447-FB8AA8D1-64B0-451B-9E4A-D52E300FAD87

P577

Q28474447-C478C1DB-8D8C-4C5B-BB98-E0FE486C288A

P5875

Q28474447-2E864EEF-5E78-4FA9-88C9-B0053B072B17

P698

Q28474447-8807914F-549D-47E6-A578-52C3A3889055

P921

Q28474447-2AD9FDA7-2778-41B4-B445-45D185C9A7B9

Q28474447-82462D78-26AB-4323-918D-1E9FDD87DE19

P932

Q28474447-AA754D31-4665-435F-94F5-168D161C6FA6

P3181

P356

JOURNAL.PMED.0050253

P1433

P1476

A randomised controlled trial ...... ciparum treatment in pregnancy

@en

P2093

Elizabeth A Ashley

http://www.w3.org/2001/XMLSchema#string

Jacher Viladpai-Nguen

http://www.w3.org/2001/XMLSchema#string

Katja Wüstefeld

http://www.w3.org/2001/XMLSchema#string

Lily Keereecharoen

http://www.w3.org/2001/XMLSchema#string

Lucy Phaiphun

http://www.w3.org/2001/XMLSchema#string

Marion Barends

http://www.w3.org/2001/XMLSchema#string

Natthapon Laochan

http://www.w3.org/2001/XMLSchema#string

Niklas Lindegardh

http://www.w3.org/2001/XMLSchema#string

Saw Oo Tan

http://www.w3.org/2001/XMLSchema#string

P2860

A randomized trial of artemether-lumefantrine versus mefloquine-artesunate for the treatment of uncomplicated multi-drug resistant Plasmodium falciparum on the western border of Thailand.

The safety of artemisinins during pregnancy: a pressing question

A randomized controlled pilot trial of azithromycin or artesunate added to sulfadoxine-pyrimethamine as treatment for malaria in pregnant women

Mefloquine resistance in Plasmodium falciparum and increased pfmdr1 gene copy number

Clinical pharmacokinetics and pharmacodynamics and pharmacodynamics of artemether-lumefantrine.

Artemether-lumefantrine for the treatment of multidrug-resistant falciparum malaria.

The epidemiology and burden of Plasmodium falciparum-related anemia among pregnant women in sub-Saharan Africa.

Intrahost selection of Plasmodium falciparum pfmdr1 alleles after antimalarial treatment on the northwestern border of Thailand.

Molecular and pharmacological determinants of the therapeutic response to artemether-lumefantrine in multidrug-resistant Plasmodium falciparum malaria

Plasmodium falciparum antimalarial drug susceptibility on the north-western border of Thailand during five years of extensive use of artesunate-mefloquine.

P304

e253

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1654441

http://www.w3.org/2001/XMLSchema#string

P356

10.1371/JOURNAL.PMED.0050253

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P50

Nicholas John White

François H Nosten

Pratap Singhasivanon

Mupawjay Pimanpanarak

P577

2008-12-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

24181262

http://www.w3.org/2001/XMLSchema#string

P698

19265453

http://www.w3.org/2001/XMLSchema#string

P921

Plasmodium falciparum

P932

2605900

http://www.w3.org/2001/XMLSchema#string